Published Aug 20, 2026, 4:49 PM ET · Updated 3 months ago · 1 source
Cancer vaccine prevents deadly melanoma from returning or spreading in landmark trial
foxbiz
·
Original Report
INFERY
Merck and Moderna's mRNA cancer vaccine hit its Phase 3 trial endpoint, showing improved recurrence-free survival in melanoma patients after surgery.